Open in interactive viewer → charts, metric popovers & call review

The smart ring that became an AI factory: Corvex's reverse-merger metamorphosis, and its 58% drawdown

Movano Health, a cash-starved FDA wearable, reverse-merged into an AI-infrastructure 'neo-cloud' — and the equity has already given back nearly two-thirds of its post-deal pop.
MOVE · Earnings Call · 2026-05-22

A company that erased itself

Corvex, Inc. (MOVE) is, in the most literal sense, no longer the business it was when 2026 began. Through a March 19 reverse merger, the entity formerly known as Movano Health — a wearable start-up that spent 2022 through 2025 chasing FDA clearance of a medical smart ring — absorbed Corvex OpCo and was rebaptized as an AI-infrastructure platform. The March-quarter call is essentially a founding document for a new corporation. The keyword ledger confirms the rupture: a year ago the top themes were EvieMED Ring and the FDA decision process; today the vocabulary is entirely confidential computing, AI factory deployments, and a token factory for inference. Almost nothing carried over but the ticker. The old company was chasing a different holy grail. On the November 2024 call, then-CEO John Mastrototaro described cuffless blood-pressure results where “we were able to meet and be within the FDA accuracy criteria for blood pressure monitoring” — John Mastrototaro, Chief Executive Officer · 2024-11-14 — the "Holy Grail" of seamless, automatic longitudinal health tracking. The commercial roadmap was built on B2B healthcare deals that would, as Michael Soule put it, “unlock a host of initiatives across clinical trials, remote patient monitoring” — Michael Soule, Business or Commercial Leader (inferred from context) · 2024-08-14. That entire plan is now wound down. CFO Jeremy Cogan was careful to flag that reported results “only reflect Corvex's AI platform for 12 days in the quarter, whereas our legacy health care operations were included on a full quarter basis” — Jeremy Cogan, Chief Financial Officer · 2026-05-22 — even the numbers straddle two company lifetimes.

The new story, and the wave it is riding

New CEO Jay Crystal frames the pivot as an infrastructure epoch. “We believe AI is driving a once-in-a-generation transformation in global computing infrastructure” — Jay Crystal, Chief Executive Officer · 2026-05-22, he opened, arguing Corvex “combines AI infrastructure, AI inference software and confidential computing technology to help customers train, deploy and secure AI workloads at industrial scale” — Jay Crystal, Chief Executive Officer · 2026-05-22.

Corvex is being built to address this shift. Our platform combines AI infrastructure, AI inference software and confidential computing technology to help customers train, deploy and secure AI workloads at industrial scale.

Jay Crystal, Chief Executive Officer · 2026-05-22
The pitch — publicly traded, vertically integrated, "neo-cloud" focused on secure AI workloads — targets some of the fastest-growing budget lines in tech, and Corvex is not alone on the runway. Days earlier, NVIDIA's call leaned on confidential computing as a genuine capability, and the tape is clearly voting for compute: 90-day advancers are crowded with AI data centers, "HPC data centers", "co packaged optics", and "joules per terahash". Peers reporting the same window — GDS, 0992.HK — anchor themselves to AI-server and AI-cloud demand. So Corvex is riding a real global wave. That is also the problem: this is a $3.65M-pro-forma-revenue entrant asking to be funded like a hyperscaler supplier, up against the very names it lists as customers, and leaning on unproven claims that software licensing will be a "lead source" for hardware deals.

The numbers, and the tape's verdict

The financial record is a fast-forward of priorities. Capital expenditure exploded to $6M in the quarter — up over 100,000% yoy from a legacy business that spent essentially nothing on capex — against just $3.65M of pro-forma revenue, so the company is now outspending its own top line on machines. In the same quarter R&D fell 66% yoy: the healthcare lab is being retired to fund AI capacity. The reverse merger bought time — cash runway jumped from ~1.3x to 6.8x quarters with over $29M of cash — but stock-based compensation is up 628% and the buildout is only beginning; capex is set to climb far beyond $6M a quarter as clusters from 2,000 to 100,000 GPUs are stood up. The equity has already rendered a verdict. After the May 22 call the stock actually ran to a $24.46 peak on June 26 — then fell 58% over eleven weeks, 64% off the high by late August. And the transcript is notable for a conspicuous omission: no Q&A. Management closed with a terse “we will not be taking questions on today's call” — Jay Crystal, Chief Executive Officer · 2026-05-22 — an unusual posture for a company asking investors to trust a brand-new strategy. With the entire narrative resting on execution against the most sophisticated compute buyers on earth, the tape is signaling a modest reality check: a ~$1.6B market cap on a $3.65M-quarter neo-cloud is a thesis that has yet to earn its price.